文献速递胸部CT

CO-RADS与RSNA分类系统评估疑似COVID-19胸部CT诊断性能的Meta分析

Diagnostic Performance of CO-RADS and the RSNA Classification System in Evaluating COVID-19 at Chest CT: A Meta-Analysis.
PubMed 文献 · Radiol Cardiothorac Imaging · 2021-01-14

该Meta分析纳入9项研究共3283例临床疑似COVID-19患者,评估CO-RADS与RSNA分类对胸部CT的诊断性能;CO-RADS和RSNA分类级别越高,COVID-19感染频率越高,不同阈值下敏感度与特异度呈相应变化。

要点

  • CO-RADS 5类COVID-19合并频率89.6%,RSNA典型类92.5%,高级别类别感染概率高。
  • CO-RADS≥3阈值敏感度92.5%、特异度69.2%;≥4阈值敏感度85.8%、特异度84.6%。
  • RSNA indeterminate阈值敏感度90.2%、特异度75.1%;typical阈值敏感度65.2%、特异度94.9%。

诊断标准与关键数值

  • CO-RADS各类别COVID-19合并频率:1类8.8%、2类11.1%、3类24.6%、4类61.9%、5类89.6%。
  • RSNA分类各类别COVID-19合并频率:negative 14.4%、atypical 5.7%、indeterminate 44.9%、typical 92.5%。
  • CO-RADS阈值≥3:敏感度92.5%(95% CI: 87.1, 95.7),特异度69.2%(95% CI: 60.8, 76.4)。
  • CO-RADS阈值≥4:敏感度85.8%(95% CI: 78.7, 90.9),特异度84.6%(95% CI: 79.5, 88.5)。
  • CO-RADS阈值5:敏感度70.4%(95% CI: 60.2, 78.9),特异度93.1%(95% CI: 87.7, 96.2)。

临床应用与阅片要点

  • 采用CO-RADS或RSNA分类报告胸部CT时,高级别类别提示COVID-19感染频率更高。
  • 选择阈值需权衡敏感度与特异度:CO-RADS≥3敏感度高,CO-RADS 5或RSNA typical特异度高。

局限性

  • 4项研究存在初始RT-PCR阴性后未重复RT-PCR而持续临床怀疑的风险偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To determine the diagnostic performance of the COVID-19 Reporting and Data System (CO-RADS) and the Radiological Society of North America (RSNA) categorizations in patients with clinically suspected coronavirus disease 2019 (COVID-19) infection.

MATERIALS AND METHODS: In this meta-analysis, studies from 2020, up to August 24, 2020 were assessed for inclusion criteria of studies that used CO-RADS or the RSNA categories for scoring chest CT in patients with suspected COVID-19. A total of 186 studies were identified. After review of abstracts and text, a total of nine studies were included in this study. Patient information (n¸ age, sex), CO-RADS and RSNA scoring categories, and other study characteristics were extracted. Study quality was assessed with the QUADAS-2 tool. Meta-analysis was performed with a random effects model.

RESULTS: Nine studies (3283 patients) were included. Overall study quality was good, except for risk of non-performance of repeated reverse transcriptase polymerase chain reaction (RT-PCR) after negative initial RT-PCR and persistent clinical suspicion in four studies. Pooled COVID-19 frequencies in CO-RADS categories were: 1, 8.8%; 2, 11.1%; 3, 24.6%; 4, 61.9%; and 5, 89.6%. Pooled COVID-19 frequencies in RSNA classification categories were: negative 14.4%; atypical, 5.7%; indeterminate, 44.9%; and typical, 92.5%. Pooled pairs of sensitivity and specificity using CO-RADS thresholds were the following: at least 3, 92.5% (95% CI: 87.1, 95.7) and 69.2% (95%: CI: 60.8, 76.4); at least 4, 85.8% (95% CI: 78.7, 90.9) and 84.6% (95% CI: 79.5, 88.5); and 5, 70.4% (95% CI: 60.2, 78.9) and 93.1% (95% CI: 87.7, 96.2). Pooled pairs of sensitivity and specificity using RSNA classification thresholds for indeterminate were 90.2% (95% CI: 87.5, 92.3) and 75.1% (95% CI: 68.9, 80.4) and for typical were 65.2% (95% CI: 37.0, 85.7) and 94.9% (95% CI: 86.4, 98.2).

CONCLUSION: COVID-19 infection frequency was higher in patients categorized with higher CORADS and RSNA classification categories.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Kwee RM, Adams HJA, Kwee TC, et al. Diagnostic Performance of CO-RADS and the RSNA Classification System in Evaluating COVID-19 at Chest CT: A Meta-Analysis. Radiol Cardiothorac Imaging. 2021. PMID: 33778660. doi:10.1148/ryct.2021200510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。